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Will iam R. Wagner, PhD,  Pittsburgh, Pa. 
Purpose: Retroviral transduction for genetic enhancement of endothelial cell (EC) anti- 
thrombotic phenotype offers potential for improving the dinical success of vascular graft 
seeding; however, application of this technique may bring concomitant al eration in cell 
functionality. 
Methods: Human microvascular ECs were transduced with a retroviral vector encoding for 
the marker gene ]~-galactosidase. Transduced endothelial cells (rtECs) and nontrans- 
duced endothelial cells (ntECs) were evaluated by flow cytometry for expression of 
intercellular adhesion molecule (ICAM)-I and tissue factor (TF) on both smooth (cov- 
erslips) and graft (Dacron, 6 mm inside diameter) surfaces under static and shear exposed 
conditions. Graft EC retention was measured after 6-hour pulsatile perfusions. Platelet 
and neutrophil adherence was measured on perfused coverslips. 
Results: Lower levels of ICAM-1 were expressed by rtECs on coverslips trader both static 
(p < 0.01 vs static ntECs) and shear exposed conditions (p < 0.01 vs static and shear 
ntECs). Accordingly, fewer polymorphonuclear leukocytes adhered to rtEC monolayers 
(p < 0.01 vs ntECs). No difference in ICAM-1 and TF expression by static graft seeded 
rtECs and ntECs was observed. However, graft-seeded rtECs that were exposed to wall 
shear stress displayed less TF than sheared ntECs (p < 0.05). Transduction did not affect 
EC retention to the sheared graft surface. 
Conclusions: These data suggest that retroviral transduction does not elicit a prothrom- 
botic/proinflammatory phenotype, rather indices of these states appear in some condi- 
tions to be reduced. Further, transduction does not adversely affect EC adherence to 
Dacron graft surfaces under arterial hemodynamics. (J Vasc Surg 1997;26:676-84.) 
Numerous tudies have evaluated the potential of  
endothelial cell (EC) seeding to improve vascular 
graft biocompatibility. Although animal models have 
demonstrated improved patency, clinical trials have 
been largely unable to show significant differences in 
long-term patency rates. 1 Gene transfer techniques 
for enhancing specific thromboresistant properties of 
ECs have rejuvenated the hopes of achieving in- 
creased biocompatibility and patency of EC-seeded 
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vascular grafts. One of the more promising gene 
delivery systems is viral vectors. A number of genes 
have been successfully inserted into animal ECs using 
this method of gene transfer, resulting in increased 
production of substances such as human tissue plas- 
minogen activator (tPA) 2 and inducible nitric oxide 
synthase (iNOS). 3 A key assumption i herent o EC 
gene transfer is the favorable xpression of a back- 
ground antithrombotic phenotype, but genetic ma- 
nipulation, particularly viral infection, may elicit ex- 
pression of inflammatory or procoagulant properties. 
Specifically, (wild-type) viral infection of ECs has 
been shown to result in 'increases in intercellular 
adhesion molecule ( ICAM)- I  4 and tissue factor 
(TF) s expression, monocyte and polymorphonuclear 
leukocyte (PMN) adherence, 6 surface thrombin gen- 
eration, 7,8 platelet binding, 7 and formation of 
thrombi and vessel occlusion. 9 
With this in mind, we have studied the expression 
of the important inflammatory adhesion molecule, 
ICAM-1, and procoagulant mediator, TF, on retro- 
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viral transduced ECs (rtECs) both on coverslips and 
on Dacron vascular grafts under both static and fluid 
shear conditions using flow cytometric techniques. 
We have also examined transduced and nontrans- 
duced EC (ntEC) retention on seeded vascular grafts 
exposed to pulsatile arterial hemodynamics. Finally, 
platelet and PMN adhesion to rtEC and ntEC 
monolayers was quantitatively assessed. 
M_ETHODS 
Cell culture. Cryopreserved neonatal human 
microvascular ECs (MVECs; Clonetics, San Diego), 
passages 2 through 6, were used for all experiments. 
MVECs from three different donors (with at least 
two donors per set of experiments) were used to 
eliminate any artifactual observations i olated to a 
particular cell donor. MVECs were tested previously 
by the supplier for acetylated low-density lipoprotein 
uptake and factor VIII expression relative to lcnown 
positive controls. All cells were maintained on tissue- 
culture treated polystyrene (Costar, Cambridge, 
Mass.) in endothelial basal medium (EBM) contain- 
ing 5% fetal bovine serum (FBS; both from Clonet- 
ics), and subcultured using Trypsin-ethylenediamine 
tetraacetic acid (EDTA; 0.25% Trypsin, 1 mol /L  
EDTA; Gibco BRL, Gaithersburg, Md.). 
Vector transduction. The BAGlacZ retroviral 
vector, generously provided by Dr. Paul Robbins 
(University of Pittsburgh, Vector Core Lab), was 
used to transduce half of the MVEC cultures at the 
second subculture. This replication-defective retrovi- 
ms contains the Escberichia coli [3-galactosidase g ne 
(lacZ) under the transcriptional control of a Molo- 
ney murine leukemia viral long terminal repeat pro- 
moter and a neomycin phosphotransferase g ne 
(Neo R) under control of the SV-40 promoter. The 
transduction procedure, adapted from Kahn et al. 10 
was performed 24 hours after subculture and in- 
cluded the addition of 4 ml of viral supernatant 
(approximate titer, 1.7 x 10S/ml) to each 75 cm 2 
flask. The infection procedure was repeated the fol- 
lowing day. This procedure resulted in initial trans- 
duction efficiencies of 10% to I5%. Neomycin 
(G418, Geneticin; Gibco) treatment, o eliminate 
ntECs, was started the day after the second viral 
incubation and continued through the seventh day 
after infection. After transduced MVEC colony 
formation, neomycin treatment was stopped and 
cultures were allowed to grow to confluence. All 
transduced cultures used experimentally were ver- 
ified by X-GAL staining ix for [3-D-galactosidase 
activity, and purities greater than 90% were used. 
Transduced and nontransduced cells of identical 
subculture number and cell batch were used for all 
experiments. 
Shear exposure xperiments, rtECs and ntECs 
were grown to confluence on glass coverslips (24 × 
50 mm). One third of the coverslips were placed in a 
parallel plate perfusion apparatus similar to that de- 
scribed elsewhere, 12whereas those remaining were 
kept under static medium. The perfusion system al- 
lowed for a 2.65 cm 2 area of the coverslip to be 
exposed to a wall shear stress of 2.5 dynes/cm 2 for 6 
hours at 37 ° C. This level of wall shear stress is 
estimated to be within the range of arterial shear 
found in vivo in arteries of moderate diameter. Me- 
dium 199 (M199) containing 5% FBS (Sigma) 
served as the perfusion media, which was withdrawn 
through the chamber by a syringe pump (Harvard 
Apparatus, South Natick, Mass.). Identical media 
was also added to the static cultures during the 6 
hour perfusion period. One half of the static cultures 
received human recombinant interleuldn- 113 (IL- 1 [3; 
final concentration 100 U/ml;  Sigma) concurrently 
as positive control. All equipment used was ethylene 
oxide-sterilized, and perfusions were performed un- 
der sterile conditions. The unstimulated, static cov- 
erslip cultures erved as a control to which all condi- 
tions were normalized for flow cytometric analysis. 
Vascular graft seeding. Collagen-impregnated 
woven double velour vascular graft segments (He- 
mashield, Meadox Medicals Inc., Oakland, N.J.), 6 
mm internal diameter were seeded with ntECs and 
rtECs. Two graft segments (7 cm length for perfused 
segments and 4 cm length for static segments) and 
four glass coverslips were prepared for each experi- 
ment. Before seeding, each graft segment was fitted 
with three-way stopcocks and filled with a solution of 
fibronectin (10 txg/cm 2, Sigma) in Tris buffered (pH 
7.4) saline solution for 45 minutes at 37 ° C. During 
this time the grafts were rotated on a hematology 
mixer (Fisher Scientific, Pittsburgh). After incubation, 
the fibronectin solution was removed, and the grafts 
were allowed to air dry. After drying, cell suspensions 
prepared from confluent culture flasks (approximate 
seeding density, 3 × 10 s cells/cm 2) were introduced to 
each segment, completely filling the lumen. The grafts 
were then incubated at 37 ° C for a total of 105 minutes 
while mixing. After the seeding was complete, the stop- 
cocks were removed and grafts were incubated in fresh 
EBM for 4 days before perfusion. 
Graft perfusions. An arterial pulsatile duplicat- 
ing apparatus (PDA) in vitro perfusion system was 
used for the purpose of evaluating both cellular re- 
tention and the expression of ][CAM- i and TF on the 
cells on the graft surface after exposure to shear 
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stress. The PDA circuit, described elsewhere la and 
recently used for a similar study, 14 was driven by a 
Bio-Medicus centrifugal pump (Medtronic, Eden 
Prairie, Minn.) and allowed for an rtEC-seedcd and 
an ntEC-seeded graft segment o be perfused in 
parallel under identical hemodynamic conditions. 
Pulsatility was provided at a rate of 80 pulses per 
minute by a flow-occluding valve whose linear mo- 
tion provided for repeatable pressure waveforms. 
Pressure was monitored by transducers located prox- 
imally and distally to the graft segments and main- 
tained at approximately 120/80 mm Hg. Flow rates 
for each graft were monitored by an in-line ultrasonic 
flow probe (model 4N, Transonics Systems Inc., 
Ithaca, N.Y.) and flowmeter (model T106, Transon- 
ics) and maintained atapproximately 300 cm3/min, 
resulting in an approximate wall shear stress of 2.5 
dynes/cm 2. Sterile M199 containing 5% FBS was 
used as the perfusion medium and was maintained at
37 ° C with 5% CO 2. Medium samples were taken 
periodically and analyzed on an acid-base laboratory 
(ABL 330, Radiometer America, Inc., Copenhagen, 
Denmark) to monitor pH and partial 02 and CO 2 
pressures. Grafts were perfused for 6 hours, during 
which time static graft segments and coverslip cul- 
tures were incubated with medium identical to that 
used in the perfusions. One half of the coverslip 
cultures and grafts received IL-I[3 (100 U/ml) to 
serve as positive controls. Three-centimeter seg- 
ments from the middle of each perfused graft, and all 
static grafts and coverslips, were analyzed with flow 
cytometry immediately after the 6-hour perfusion 
period. Proximal and distal sections of the graft were 
used to quantify cell retention. 
Cell retention quantification. Before perfu- 
sion, two 0.5 cm length segments of each graft o be 
perfused were removed and analyzed to determine 
initial cell number. MTT [3-(4,5-dimcthylthiazol-2- 
yl)-2,5-diphenyl tetrazolium bromide] analysis, de- 
scribed elsewhere,1 ~ was used to determine viable cell 
number on the grafts. This technique uses cleavage 
of the tetrazolium salt MTT into a purple formazan 
product by mitochondrial enzymes in viable cells. 
Analysis on a UV/Vis Spectrometer (Lambda 2; Per- 
kin Elmer, Norwalk, Conn.) at 570 nm, and prior 
establishment of a linear calibration curve with 
MVECs (R 2 = 0.931), allowed conversion between 
absorbance and cell number. 
Flow cytometry. The expression of ICAM-1 
and TF on the MVEC surface was measured by direct 
and indirect immunofluorescence respectively with 
flow cytometry.16,17 All ce ls analyzed by flow cytom- 
etry were removed from their respective surface via a 
solution of c011agenase (type P, 0.2 mg/ml; Boehr- 
inger Mannheim, Indianapolis) and 4 mmol/L 
EDTA in phosphate-buffered saline solution. Each 
cell sample, consisting of approximately 1 × 105 
cells, was dual antibody (Ab) labeled through apro- 
cess consisting of three separate Ab incubations. 
Samples received unconjugated mouse antihuman 
TF monoclonal ntibody (mAb; Biodesign Interna- 
tional, Kennebunk, Me.) followed by a secondary 
FITC-conjugated antimouse immunoglobulin (IgG) 
F(Ab)2 (Sigma) and a tertiary phycoerythrin conju- 
gated mouse antihuman ICAM-1 (CD54) mAb (Im- 
munotech Inc., Westbrook, Me.), all at predeter- 
mined saturating concentrations. This procedure was 
also used to label separate aliquots of both ntECs and 
rtECs, with substitution ofequivalent concentrations 
of irrelevant mouse isotype matched mAb, to deter- 
mine the level of background nonspecific labeling. 
MI cells were fixed in 1% paraformaldehyde in phos- 
phate-buffered saline solution for 30 minutes after 
labeling. A minimum of 5000 cells were analyzed 
using a Becton Dicldnson FACScan (Becton Dicldn- 
son, Lincoln Park, N.J.) flow cytometer. Percent 
expression Was determined by including cells whose 
fluorescence intensity was greater than 98% of those 
labeled with the irrelevant isotype control. 
Quantification of neutrophil adhesion. A 
PMN suspension was prepared from flesh human 
venous blood anticoagulated with heparin (4 U/ml; 
Upjohn Company, Kalamazoo, Mich.), asdescribed 
elsewhere. 18 Antecubital vein blood was obtained 
after informed consent from nonsmoking donors 
who had not taken any platelet-active drugs in the 
past 10 days. PMNs were suspended in EBM to a 
final concentration of 1 × 106 cells/ml at 37 ° C. 
Monolayers of untreated or IL- 1 t3-treated (100 U /  
ml, 6 hours) ntECs and rtECs were placed in the 
perfusion chamber, described previously, mounted 
on the stage of an inverted phase-contrast micro- 
scope (Axiovert 35; Carl Zeiss Inc., Thornwood, 
N.Y.) and perfused initially for 2 minutes with EBM 
at 37 ° C. The PMN suspension was then perfused 
through the chamber at a constant wall shear stress of 
approximately 2.5 dynes/cm 2 for 10 minutes. A 3- 
minute PMN-ffee EBM wash immediately followed 
the PMN perfusion at the identical wall shear stress 
for removal of any PMNs not adhering to 
the surface. Adherent PMNs were identified and 
counted in 10 fields per coverslip at 400× by random 
field sampling using digital image processing. 
Quantification of platelet adhesion. Monolay- 
ers of untreated or phorbol 12-myristate 13-acetate 
(PMA, 20 ng/ml for 6 hours; Sigma)-treated ntECs 
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Fig. 1. Flow cytometric analysis oflCAM-1 and TF expression, ntEC and rtEC on coverslips 
were exposed to 2.5 dynes/cm 2 wall shear stress for 6 hours or remained static. IL-I[3 (100 
U/ml) was added to one half of the static cultures as positive control. All conditions were 
normalized to static ntEC cultures. Values shown represent normalized percentage ofpositive 
fluorescent cells for ICAM-1 (A), and TF (B). Data are expressed as mean + SEM. **p < 0.01 
versus tatic ntEC. (Other significant differences of interest, but not noted on the graphs: A: rtEC 
w/shear vs ntEC w/shear, rtEC vs rtEC IL-I3, p < 0.01; B: rtEC vs rtEC IL-113, p < 0.01.) 
and rtECs were placed in the perfusion chamber, as 
described previously for PMN adhesion, and per- 
fused initially for 2 minutes with EBM at 37 ° C. 
Whole blood at 37 ° C anticoagulated with heparin 
(4 U /ml )  was then perfused for 5 minutes over the 
cell monolayers at a wall shear stress of approximately 
2.5 dynes/cm 2. After a 5-minute EBM wash at the 
same shear, to remove red blood cells and nonadher- 
ent platelets, the slide was removed and the platelets 
were labeled with mouse FITC-conjugated CD42b 
IgG 1 (Gen Trak Inc., Plymouth Meeting, Pa.), bio- 
tinylated horse antimouse IgG (Vector Laboratories, 
Burlingame, Calif.) and fluorescein avidin (Vector), 
for 30 minutes each at 4 ° C. All coverslips were then 
analyzed by random field sampling, 10 fields per 
coverslip, at 200 × using fluorescent microscopy and 
digital image processing. Captured images were ana- 
lyzed for percentage of area occupied by adherent 
platelets in each field. 
Statistical analysis. Results are expressed as 
mean _+ SEM. Statistical analyses were performed 
using repeated measures analysis of variance with the 
Newman-Keuls test for post-hoe group comparisons. 
Statistical significance was defined as a p value less 
than 0.05. 
RESULTS 
Endothel ial  expression of  ICAM-1 and TF on 
coverslips. Static cultures of ntECs, prepared for 
each experiment and of the same subculture, served 
as controls to which all other conditions were nor- 
malized. This was done not only for comparison 
purposes, but also to eliminate any drift in baseline 
expression for cells of varying subculture number. 
Normalized surface expression ,of both ICAM-1 and 
TF, as detected by flow cytometry, are depicted in 
Fig. 1. Most notable is the significantly lower level of  
ICAM-1 expression on retroviral transduced cells 
exposed to shear stress and under static culture (both 
p < 0.01 vs static control). Exposure to shear stress 
led to lower expression of ICA~VI-1 on both ntECs 
and rtECs, although only the transduced cells were 
significantly lower than the static ntEC control. 
rtECs exposed to Shear also showed significantly 
lower ICAM- I  expression as compared with ntECs 
under identical shear (p < 0.01). Similar trends also 
held for TF expression, although no significant dif- 
ferences were detected. As expected, exposure to 
IL-l[3 significantly increased expression of both 
ICAM-1 and TF for ntECs and rtECs (p < 0.01 vs 
static, nonstimnlated ntECs and rtECs, respectively). 
Platelet adhesion to MVECs.  Platelet adhesion 
to ntEC and rtEC monolayers at 2.5 dynes/cm 2 wall 
shear stress is presented in Fig. 2, A. The data repre- 
sent the total area of fluorescent platelet hrombus as 
a percentage of the total analyzed image area. No 
significant difference in platelet coverage was seen 
between tECs and rtECs (0.4'9% _+ 0.06% vs 0.51% 
_+ 0.05%). Significant differences (p < 0.01) were 
detected between PMA-stimulated and comparable 
unstimulated cells, for both ntECs and rtECs. 
PMN adhesion to MVECs.  PMN adherence to 
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Fig. 2. Platelet (A) and PMN (B) adhesion to ntEC and rtEC monolayers. Confluent cover- 
slips were perfused for 5 minutes at a wall shear stress of 2.5 dynes/cm 2 for platelet adhesion 
data, and for 10 minutes at 2.5 dynes/cm 2 for PMN adhesion data. % platelet coverage, 
percentage of total image area occupied by adherent platelets. Data are expressed as mean + 
SEM. **p < 0.01 versus ntEC. (Other significant differences of interest, but not noted on the 
graphs: A: rtEC vs rtEC PMA, p < 0.01; B: rtEC vs rtEC IL-I~3, p < 0.01.) 
ntEC and rtEC monolayers at a wall shear stress of 
2 .5dynes/cm 2 is presented in Fig. 2, B. The number 
of adherent PMNs to rtEC monolayers was signifi- 
cantly less (p < 0.01) than that of the ntEC mono- 
layers (35 _+ 5 PMNs/mm 2 vs 94 _+ 9 PMNs/mm2).  
IL-lJ~-stimulated ntECs and rtECs showed signifi- 
candy higher numbers of adherent PMNs in compar- 
ison with their respective nonstimulated counter- 
parts (p < 0.01). 
Endothel ial  expression o f  ICAM-1 and TF on 
Dacron. Flow cytometry data wcre normalized to 
static cultures of ntEC on coverslips, of the same 
subculture, that were prepared for each cxperiment 
and served as control. Surface expression of ICAM-1 
and TF on ECs that were seeded onto fibronectin- 
coated Dacron grafts, as dctccted by flow cytometry, 
is presented in Fig. 3. 
Similar behavior between ntECs and rtECs on 
the graft surface was seen for both TF and ICAM-1 
expression. Although not significant, both showed 
lower ICAM-1 expression and slightly highcr TF 
expression than that of ntEC controls. Exposure to 
shear stress resulted in increased TF and ICAM-1 
expression for both ntECs and rtECs on the graft 
surface, above their respective static graft conditions. 
However, only for TF expression of  ntECs on grafts 
exposed to shear was this increase significant (p < 
0.01 vs ntEC static control; p < 0.05 vs rtEC shear). 
Exposure of static grafts to IL - I~,  as a positive con- 
trol, resulted in significant increases of both TF and 
ICAM- I  for ntECs and rtECs. 
EC retention on Dacron after shear stress ex- 
posure. The percentage of viable ECs remaining 
attached to the graft surface after the 6-hour expo- 
sure to pulsatile arterial shear is shown in Fig. 4. No 
significant differences were observed between the 
number of viable ntECs remaining on the grafts as 
compared with rtECs. This includes comparison of 
both proximal and distal segments and total number 
of cells remaining, regardless of position with respect 
to the direction of flow. The total percentage of 
viable ntECs remaining adherent o the graft was 
81% +_ 5% vs 72% --- 3% for rtECs (p = 0.12). 
Individually, the number of viable cells remaining on 
the grafts proximal to the direction of flow was 76% 
-+ 8% for ntECs and 68% + 6% for rtECs, whereas 
the number emaining on distal segments was 85% + 
5% for ntECs and 75% + 3% for rtECs. 
DISCUSSION 
Contrary to the hypothesis that viral transduction 
may adversely alter EC phenotype, our data suggest 
that retroviral transduction of human MVECs does 
not elicit either an inflammatory or procoagulant 
response in vitro. The culture surface (coverslip or 
Dacron graft) and shear stress exposure on both of 
these surfaces did not alter this behavior. In fact, 
significantly lower levels of ICAM-1 were expressed 
by transduced cells under both static and shear ex- 
posed conditions on coverslips, as compared with 
nontransduced cells under identical conditions. De- 
creased PMN adhesion to rtEC monolayers as corn- 
JOURNAL OF VASCULAR SURGERY 
Volume 26, Number 4 Jankowski et al. 681 
300 600 
~, (.,,,o, ** (°=to, %1 
~" 200 In=7) ~ 400 ** 
- ,oo  
(n=28) (n=lO) o,0  ,001 / 
ntEC ntEC ntEC ntEC rtEC rtEC rtEC : : : * 
A control IL- 1 w/shear IL-1 w/shear E~ ntEC ntEC ntEC ntEC rtEC rtEC rtEC 
control IL-1 w/shear IL-1 w/shear 
Fig. 3. Flow cytometric analysis of ICAM-1 and TF expression on seeded MVECs. ntEC- 
seeded and rtEC-seeded Dacron grafts were exposed to 2.5 dynes/era 2 wall shear stress for 6 
hours or remained static. All conditions were normalized to static ntECs on coverslips (ntEC 
control). IL-lJ3 (100 U/ml) was added to one half of the static cultures as positive control. 
Graph values indicate normalized percentage offluorescent cells positive for ICA/Vi-1 (A) and 
TF (B) expression. Data are expressed as mean + SEM. **p < 0.01; *p < 0.05 versus static 
ntEC control. (Other significant differences of interest, but not noted on the graphs: B: ntEC 
w/shear vs rtEC w/shear, p < 0.05; ntEC vs ntEC w/shear, p < 0.01.) 
pared with ntECs further demonstrates the lower 
level of  ICAM-1 expression measured with flow cy- 
tometry, rtECs analyzed by flow cytometry exhibited 
a statistically insignificant rend toward lower TF 
expression, although no. difference in platelet adher- 
ence (which might be mediated by local thrombin 
generation in minimally anticoagulated blood) was 
seen as compared with ntEC. Similar expression of 
ICAM-1 and TF was observed for rtECs and ntECs 
seeded on Dacron. However, graft-seeded rtECs ex- 
posed to shear stress displayed significantly less TF 
than comparable ntECs. Also, transduction did not 
affect EC retention to the .graft surface (although a 
trend towards lower transduction retention was 
observed; p = 0.12). No qualitative difference in 
growth rates were seen for rtECs as compared with 
ntECs (data not shown). 
Some of the results presented in this study are 
supported by the work of other investigators for ECs 
transduced with retroviral vectors for lacZ and tPA, ~9 
and an immortalization vector. 2° tPA overproduc- 
tion and lacZ did not affect cellular attachment, pro- 
liferation, migration, or invasion as compared with 
nontransduced cells in vitro. Transduced immortal- 
ized cells in vitro did not display abnormalities in 
growth, expression of  vWF, PECAM-1, E-selectin, 
and migration of neutrophils. In addition, lower 
basal evels of VCAM-1 and ICAM-1 were observed 
for immortalized cells compared with nontransduced 
primary ECs. 2° 
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Fig. 4. MVEC retention after 6 hour pulsatile perfusions 
at 2.5 dynes/cm 2. Data are expressed as the total percent- 
age of viable ECs remaining on graft surface after perfu- 
sion, as compared with cell numbers before flow exposure. 
Two graft segments from each perfused graft were evalu- 
ated for cell retention, one proximal and one distal with 
respect to direction ofperfusate flow. 
In contrast, there arc reports in the literature that 
have found an alteration in EC function after retro- 
viral transduction. Transduction with the lacZ vector 
in vitro has been shown to result in slower prolifera- 
tion rates as well as decreased production of PGI2. 21 
In vivo, seeding of expanded polytetrafluoroethylene 
(ePTFE) grafts with lacZ-transduced canine ECs has 
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resulted in slower and incomplete ndothelialization 
at 6 weeks, as well as slower growth rates in vitro. 22 
This result was also seen for Neo R and human 
growth hormone-transduced canine ECs in vivo 
seeded onto both ePTFE and Dacron, in which 
transduced ECs appeared altered in their ability to 
adhere and grow. 23 
The differences in retroviral-transduced EC func- 
tion from one study to the next suggest hat the 
transduced vector as well as cell type, may play an 
important role. For instance, aslower in vitro growth 
rate was seen for cells transduced with the BAG 
vector (lacZ and Neo P" genes), compared with cells 
transduced with a vector encoding only the Neo e" 
gene. 22 Vector construction may be particularly im- 
portant, and offers a potential explanation for trans- 
duced cell loss in vivo as a result of possible viral 
protein surface xpression and subsequent immuno- 
logic destruction. 2a
Although neonatal in origin, the choice of human 
MVECs for this study offers the advantage of a cell 
line that might be clinically obtainable for seeding or 
sodding Vascular grafts, because large numbers of 
these cells may be obtained from readily available 
autologous adipose tissue. 24,25 Unfortunately, com- 
parison with the literature is limited by the small 
amount of studies that use this particular type of EC. 
This is especially evident for comparison with studies 
that examine uPregulation of ICAM-1 on shear-ex- 
posed ECs. Little is known about the effect of shear 
on human MVECs, although it is generally accepted 
that EC exposure to shear stress results in upregula- 
tion of ICAI"V[-I. 26,27 There is some discrepancy in 
the literature as to whether ICAM-1 upregulation is 
time- and force-dependent, 2s time-dependent but 
force-independent, 29 or transient, a° ICAM-1 up- 
regulation in response to shear did not occur for 
ntECs on coverslips or on grafts in this study. Several 
studies involving nongraft shear perfusions how that 
increases in ICAM-1 with exposure to shear do not 
always occur. Nagel et al. 29 reported no difference in 
ICAM-1 expression on HUVECs at 4 hours and 
significant differences in only 1 of 2 measurements at 
8 hours. Further, this data was at a much higher wall 
shear stress (10 dynes/cm 2 vs 2.5 dynes/cm 2 for our 
study), similar to most of the studies reported in the 
literature that use shear stresses of 8 dynes/cm 2 or 
greater. Tsuboi et al. 2s suggest that the effect of shear 
on  EC adhesion molecule xpression may vary with 
respect to species and vascular bed derivation, as 
mouse ECs derived from lymph node vessels howed 
no change in ICAM-1 expression in response to 
shear. The difference in shear-exposed results be- 
tween graft and coverslip in this study may be attrib- 
uted to material differences between the two sur- 
faces, pulsatile flow with grafts compared with steady 
flow with coverslips, or differences in actual ocal wall 
shear, which is very hard to calculate for the graft 
because of the manufactured crimping and fibrous 
nature of the graft surface. With regard to differences 
in flow conditions, variance in EC responses to pul- 
satility rather than steady flow have been widely ob- 
served. 31,32 
Although EC seeding has been performed for 
decades, few studies have examined EC phenotypic 
expression while on Dacron graft surfaces. Margiotta 
et al. 33 observed an insignificant increase in ICAM-1 
expression by ECs seeded on fibronectin-coated Da- 
cron. Tunstall et al. a4 observed an insignificant de- 
crease in TF expression by human umbilical vein ECs 
seeded on Dacron, as measured by clotting times as 
compared with culture flask polystyrene. Our results 
also showed no significant differences in ICAM-1 or 
TF expression for static graft-seeded ECs as compared 
with static coverslip controls, but do show a difference 
in response to shear as previously mentioned. 
EC retention to Dacron grafts, as reported here, 
compares well with that found in similar studies. 
Although using nonpulsatile flow, Dunn et al. 35 ob- 
served no difference in retention between sheep ve- 
nous ECs transduced with a lacZ retroviral vector as 
compared with nontransduced ECs seeded onto 
fibronectin-coated collagen-impregnated Dacron 
grafts under similar perfusion conditions. These re- 
suits are ncouraging, but also reported in the same 
study was a significantly lower rate of retention of 
ECs transduced with a tPA-producing retroviral vec- 
tor as compared with either nontransduced or lacZ 
transduced ECs. Also, Sackman et al. 36 recently re- 
ported a decrease in fibronectin receptor expression 
on ECs transduced with the Neo R gene. This change 
appears to be associated with overexpression f the 
neophosphotransferase protein, 36 and may explain 
our observed trend toward decreased transduced EC 
retention. These results suggest hat the specific ret- 
roviral vector may play an important role in the 
performance of the transduced EC, and each may 
ultimately have to be individually evaluated. 
One possible explanation for the differences in 
phenotypic expression seen between rtECs and 
ntECs may be effects related to the neomycin treat- 
ment incurred on the rtECs, and not ntECs. The use 
of neomycin treatment for transduced culture purifi- 
cation is well documented. 19,21,23 The inherently low 
transduction efficiencies with retroviral vectors make 
this treatment a necessity for effective clinical applica- 
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tion and therefore substantiates the comparison with 
nonneomycin-treated ntECs as control. 
The results presented herein have characterized 
the effects o fEC transduction with a retroviral vector 
on specific markers ofprocoagulatory and inflamma- 
tory phenotype in vitro. EC transduction with a 
marker gene did not elicit a prothrombotic/proin- 
flammatory phenotype, and in some instances indices 
of these states were reduced, nor did it adversely 
affect EC adherence to Dacron graft surfaces under 
arterial hemodynamics. This assessment of EC func- 
tion provides a useful tool for future evaluation of 
specific viral vectors for the enhancement of EC an- 
tithrombotic properties for improved graft biocom- 
patibility or for therapeutic purposes. 
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